
New research presented at the American Thoracic Society virtual symposium showed the first-in-class drug reduced severe asthma exacerbation rate by 35% vs placebo.

New research presented at the American Thoracic Society virtual symposium showed the first-in-class drug reduced severe asthma exacerbation rate by 35% vs placebo.

In COPD patients, a new study found no association between lung function decline and individual CVD outcomes, but disease exacerbations and dyspnea were implicated.

Mepolizumab (Nucala) received a new indication for the treatment of hypereosinophilic syndrome in patients aged ≥12 years.

More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.

Long-acting muscarinic antagonists, recommended as add-on therapy for asthma, are too often used as monotherapy and are linked with severe exacerbations, a new study finds.

Along with COPD, fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is now approved for the treatment of asthma in patients aged ≥18 years.

New research presented at the virtual European Respiratory Society International Congress showed "social smokers" are more than twice as likely to die of lung disease vs non-smokers.

Treatment guidelines on COVID-19 from the NIH were updated today based on data from clinical trials of hydroxychloroquine, ivermectin, and IL-6 inhibitors.

The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?

A new survey found adolescents who have ever used e-cigarettes are 5-times more likely to receive a COVID-19 diagnosis. More results at-a-glance in our new slideshow.

The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.

A new survey suggests use of e-cigarettes and dual use of e-cigarettes and traditional cigarettes are significant underlying risk factors for COVID-19 among US adolescents.

New research presented at the American Thoracic Society 2020 Virtual meeting showed the novel Theraflu Home FluTest demonstrated good sensitivity and specificity for influenza A and B viruses.

New research presented at the ATS 2020 Virtual meeting shows adolescents who use e-cigarettes along with marijuana and/or cigarette smoking have significantly higher odds of lifetime asthma.

Patient's vital signs and results of physical examination are normal; results of a previous lumbar puncture also were normal. What does the chest x-ray reveal?

Approval was awarded to AstraZeneca for an inhaled, fixed-dose combination of budesonide/glycopyrrolate/formoterol fumarate.

JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.

The proposed recommendations will allow more women and black patients to be eligible for lung cancer screening.

Prolonged "air hunger" induced during mechanical ventilation for severe COVID-19 infection can be eliminated by a change in standard of care, a new paper suggests.

Adherence to controller medication appears to have increased between early January and late March among patients with asthma and COPD, finds a new study.

Try your hand at these 8 questions based on the latest CDC guidance on rehospitalization and mortality in patients with vaping-related lung injury.

The CDC outlines 3 surge capacity strategies to help healthcare providers prioritize COVID-19-related conservation of facemasks: conventional, contingency, and crisis.

Testosterone could protect women from asthma and niacin may decrease COPD severity in men--results of 2 of these 4 studies. Read more.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.

These 6 recommendations from the CDC can aid physicians in differential diagnosis and treatment of EVALI and the flu.